Posted by Michael Wonder on 01 Mar 2021
Proposal to fully fund Mercilon 28 for oral contraception
26 February 2021 - PHARMAC is seeking feedback on a proposal to increase the subsidy to fully fund ethinyloestradiol 20 mcg with desogestrel 150 mcg tablets and 7 inert tablets (Mercilon 28) for oral contraception through a provisional agreement with Organon (New Zealand) Limited.
Please be advised that Mercilon 28 was previously supplied by Merck Sharp & Dohme (New Zealand) Limited.
